Global Surgical Site Infection Control Market Overview 2023-2028

The global surgical site infection control market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.1% during 2023-2028.

Surgical site infection control encompasses a comprehensive set of procedures, guidelines, and precautions implemented to thwart infections within the surgical area. This multifaceted approach includes the utilization of sterile techniques, meticulous sterilization of equipment, precise control of airflow within operating rooms, and scrupulous adherence to hygiene practices by the surgical team. Furthermore, it encompasses patient evaluation to identify potential infection risks, the administration of prophylactic antibiotics, meticulous skin preparation, and various preparatory measures. This collective effort effectively diminishes the incidence of infections at surgical sites, thereby enhancing patient safety, while also curbing additional medical expenses associated with treatment and prolonged hospital stays. Additionally, it minimizes postoperative complications and fosters a swifter recuperation process. The principles of surgical site infection control are applicable across a spectrum of surgical specialties, encompassing general surgery, orthopedics, and cardiovascular surgery, among others.

Global Surgical Site Infection Control Market Trends and Drivers:

The surge in global surgical procedure rates, driven by factors like an aging population, the prevalence of chronic illnesses, and advancements in medical technology, stands as a primary catalyst for the heightened demand for effective measures in controlling surgical site infections. Furthermore, there is a growing awareness among both healthcare professionals and patients regarding the critical importance of infection control, leading to increased emphasis on the implementation of such measures. Additionally, the advent of cutting-edge technologies, such as advanced sterilization equipment and antimicrobial dressings, is exerting a positive influence on the market. Furthermore, various national authorities and international organizations are actively promoting public health campaigns centered on infection prevention, a factor that is further propelling the growth of this market.

Global Surgical Site Infection Control Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation

The report segmented the market on the basis of region, product, infection type, surgery type and end user.

Breakup by Product:

• Antibiotic Prophylaxis Products
• Wound Care Dressings
• Surgical Drapes
• Surgical Clippers
• Antiseptics and Disinfectants
• Wound Irrigation Products
• Others

Breakup by Infection Type:

• Superficial Incisional SSI
• Deep Incisional SSI
• Organ or Space SSI

Breakup by Surgery Type:

• Cesarean Section
• Gastric Bypass
• Cataract Surgery
• Dental Restoration
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800